Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ASCO 2014: Did diagnostics crash the biggest cancer drug party of the year?

This article was originally published in Scrip

Executive Summary

The American Society for Clinical Oncology (ASCO) may be one of the biggest meetings in the pharma industry's calendar but diagnostics firms are increasing their role in the action. Madeleine Armstrong looks at some of the highlights, as well as a flurry of deals that show companion diagnostics are no longer bit players on the cancer scene.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC025513

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel